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Abstract: The numbers of immunocompromised individuals increase as programmes
for organ transplantation and chemotherapy
of malignant disease advance. Pulmonary
infections, which progress rapidly, are one of
the major clinical problems in these groups.
This study was designed to evaluate the
microbiology
of
pneumonia
in
immunocompromised patients and to
determine the role of Legionella pneumophila.
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Immunocompromised patients receiving
antineoplastic chemotherapy, diagnosed as
pneumonia with clinical and radiographic
findings and routine laboratory tests were
included in the study. For microbiological
diagnosis, expectorated sputum was cultured
for L. pneumophila. In addition to standard
bacterial, fungal and mycobacterial media,
specimens were examined microscopically.
Direct flourescent antibody (DFA) assay was
used for antigen detection of L. pneumophila.
By indirect flourescent antibody (IFA) assay
the sera of the patients were screened for L.
pneumophila.

Introduction
During the past decade the number of
immunocompromised patients has increased in parallel to
the increased use of high-dose chemotherapy and
immunosuppressive drugs. A compromised host who has
one or more defects in the body’s natural defence
mechanisms, is predisposed to severe, often lifethreatening infections (1,2).
A sensible approach to the diagnosis and treatment of
infections in these patients is to begin with an
appreciation of the predisposing factors, because each is
associated with an array of pathogens. The isolation and
identification of a specific pathogen permits appropiate
antibiotic management of patients with pulmonary
infections (1,2).

Of 74 sputum samples, 7 (9.5%) specimens
yielded L. pneumophila. The other isolates
were Escherichia coli (n:3), Enterobacter sp.
(n:2), Aspergillus sp. (n:3), Mycobacterium
tuberculosis (n:3), Staphylococcus aureus
(n:1), yeasts (n:10), Nocardia sp. (n:2) and
flora
members
(n:43).
Antibiotic
supplemented media and acid treatment was
found superior for the isolation of L.
pneumophila. Direct microscopic evaluation
was necessary to support the culture results.
DFA assay had 85% sensitivity and 100%
specificity. Of 3 sera screened by IFA for L.
pneumophila antibodies, 2 had the titres
1/256, indicating the disease.
Our results showed that L. pneumophila has
an important role among the respiratory
pathogens in immunocompromised patients,
and it may be useful if techniques for isolation
and identification of this pathogen are added
to routine culturing programmes.
Key
Words:
L.
pneumophila,
immunocompromised patients, pulmonary
infection, diagnosis.

This study was designed to evaluate the microbiology
of pneumonia in immunocompromised patients at the
Osmangazi University Medical Faculty Hospital and to
compare the results with those of previous reports. The
role of L. pneumophila and microbiological techniques for
isolation and identification of L. pneumophila were also
discussed.

Materials and Methods
Immunocompromised patients with pneumonia
admitted to the Department of Chest Disease and
Haematology Clinics of the Medical Faculty of Osmangazi
University over a 1- yr period from 1 November 1995 to
31 March 1997 were eligible for the study. Criteria for
hospitalization were at the discretion of the clinic from
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which the patient was admitted. Outpatient diagnostic
and theurapeutic interventions were performed. Inclusion
criteria were as follows:
1) patients > 20 yr of age
2) pulmonary infiltrate on chest radiograph, and

DFA for the antigen of L. pneumophila serogroup 114 was done on sputum (Fresenius Diagnostics). For L.
pneumophila serogroup 1-8, serologic tests were done by
IFA (Fresenius Diagnostics). For this purpose, a single set
of sera was collected from 3 patients and screened for L.
pneumophila serogroup 1-8 by IFA assay.

3) clinical findings of one “major criterium”: cough,
sputum production of fever > 37.8°C; or two “minor
criteria”: pleuritic chest pain, dyspnea, altered mental
status, pulmonary consolidation by physical examination
3
or white blood cell count > 12.000/mm . Patients were
excluded if chest roentgenograms did not reveal that
infiltrate or radiographic abnormalities were attributable
to a non-infectious aetiology. Neutropenic patients
receiving antineoplastic chemotherapy were included in
the study. The patients were considered neutropenic if
the granulocyte count was < 1.000/mm3.

For microscopic evaluation, all sputum samples were
stained with Gram’s and Erhlich Ziehl Neelsen (EZN)
stains. Sputum smears with a paucity of flora members
and a large number of neutrophils and small, pleomorphic
faintly staining Gram-negative rods supported the
diagnosis if growth was obtained by culture (3,4).

Routine tests obtained upon admission included chest
roentgenograms, complete blood count and serum
electrolytes (3).

Table 1.

For microbiological diagnosis, expectorated sputum
was obtained. Standard bacterial cultures were
performed by inoculation of the specimen onto 5% sheep
blood, chocolate, and Eosin Methylene Blue (EMB) (Difco)
agars. Mycobacterial cultures (Bactec system and
Löwenstein Jensen medium-Difco) and fungal cultures
(Sabouraud Dextrose Agar-SDA, Difco) were also made.
The culture for Legionella sp. was made using
Buffered Charcoal Yeast Extract Agar (BCYE) and BMPA
containing cefamandol, polymyxin B and anisomycin
(BCYE-selective agars, BCYE-s) (Oxoid). The culture
results before and after acid treatment of sputum (HCIKCI buffer, ph: 2.2) with BCYE and BCYE-selective agars
were compared. All plates were incubated at 37°C for
24-28 h in an aerobic atmosphere. After examination and
recording of the results, blood agar, EMB and SDA plates
were discarded, whereas BCYE and BCYE-s agar plates
were incubated for 5 days. All isolates were identified by
standard procedures and then by the Sceptor system.
Colonies suspected for Legionella were removed and
stained with Gram’s stain. When Gram-negative
coccobacillary or filamentous forms resembling the
members of the family Legionellaceae were observed,
biochemical tests were performed, including catalase,
oxidase, urease, nitrate, gelatinase and hippurate
hydrolysis tests.
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A total of 74 immunocompromised patients were
included in this study. The distributions according to age,
sex and primary pathology are listed in Table 1.

Characteristics of patients.

Characteristics
Mean age, yr (range)
Male / Female
Primary pathology CLL
NHL
ANLL
HD
ALL
Renal transplant
Bronchial carcinoma
Malignant mesothelioma

No of patients (No: 74)
57.3 (22-75)
39 / 9
7
9
3
5
1
2
44
3

ANLL: Acute nonlymphocytic leukemia
NHL: Non-Hodgkin lymphoma
ALL: Acute lymphoblastic leukemia
HD: Hodgkin’s disease
CLL: Chronic lymphocytic leukemia

If the patients were diagnosed with pneumonia due to
L. pneumophila, they were treated with erythromycin or
roxitromycin. Improvement of the patient was defined as
clinical improvement with negative microbiological
diagnostic test.

Results
Of 74 sputum specimens, 7 specimens yielded L.
pneumophila by culturing and direct microscopic
examination. The distribution of organisms isolated from
sputum samples is listed in Table 2.

L. pneumophila was isolated from the sputum samples
of 7 patients. The characteristics and outcomes of these
patients are given in Table 3.
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Table 2.

The distribution of organisms isolated from sputum
samples.

ISOLATE

No

%

L. pneumophila
E. coli
Enterobacter sp.
Aspergillus sp.
M. tuberculosis
S. aureus
Yeast
Nocardia sp.
Flora members

7
3
2
3
3
1
10
2
43

9.5
4.1
2.7
4.1
4.1
1.3
13.5
2.7
58.0

Table 3.

Of 7 sputum specimens including L. pneumophila, DFA
assay yielded positive results for 6 specimens (85%
sensitivity) and no cross reaction was present. Of 3 sera
screened by IFA for L. pneumophila antibodies, the titres
were 1/256 for 2 patients, indicating acute disease, and
negative for one patient. DFA and antibody detection
results supported the results obtained by culture and
microscopic evaluation. The comparison of culturing
results with DFA and serology results is shown in Table 4.

The characteristics of the patients.

Patient
No

Age
(yr)

Sex

1(SC)

62

M

Bronchial Cancer

Yes

Cough, malaise

No

2(‹Y)

65

M

Bronchial Cancer

Yes

Dyspnea, productive
cough, fever,
Malaise

3(EÇ)

51

M

Bronchial Cancer

Yes

4(NY)

70

M

Bronchial Cancer

5(NB)

52

M

6(AP)

69

7(AY)

63

Patient
No

1
2
3
4
5
6
7

Diagnosis

Cyctotoxic therapy
and/or
Corticosteroid

Therapy

Outcome

Heterogenic
density

Roxitromycin

Improved

No

Bilateral
patchy
infiltrate

Roxitromycin

Imropved

Bloody sputum
Fever, malaise

No

Infiltration
and cavitaray
lesion in left
lower lobe

Roxitromycin

Improved

Yes

Dyspnea, cough,
Chest pain, fever
Malaise

No

Patchy
density in
right lower
lobe, pleural
effusion

(He refused
therapy)

Improved

SLE

Yes

Cough

Yes

Bilateral
patchy
infiltrate

Eryhromycin

Improved

M

KLL

Yes

Productive cough,
Fever

Yes

Bilateral
patchy
infiltrate

Eryhromycin

Improved

F

Lymphoma

Yes

Non-productive
cough, fever

Yes

Unilateral
patchy
density

Eryhromycin

Improved

CULTURE
BCYE
Acid
treatment

No acid
treatment

BCYE-S
Acid
No acid
treatment
treatment

Positive
Positive
Positive
Positive
Positive
Negative
Positive

Positive
Positive
Positive
Positive
Positive
Negative
Negative

Positive
Positive
Positive
Positive
Positive
Positive
Positive

Positive
Positive
Positive
Positive
Positive
Negative
Positive

Symptoms

Neutropenia

DFA

SEROLOGY

Positive
Positive
Negative
Positive
Positive
Positive
Positive

NT
1/256
1/256
NT
NT
NT
Negative

Chest
X-ray

Table 4.

The results obtained by culturing,
DFA and IFA assays.

NT: Not tested
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The isolation of L. pneumophila was found to be
difficult with BCYE agar. However, BCYE-s agar allowed
us to see the typical colonies easily, and pure culture was
easily obtainable from this medium. In our study, all L.
pneumophila isolates could be isolated as a pure culture by
using BCYE-s agar whereas the isolates were inhibited by
the flora members and not distinguished by BCYE agar.
After acid treatment of sputum samples, the flora
members were inhibited, and thus isolation was easy, as
BCYE-s agar. When the sputum was acid treated and
inoculated onto BCYE agar, growth was obtained in 6
samples, similar to inoculating onto BCYE-s agar without
acid treatment. But all samples were found positive for L.
pneumophila when both acid treatment and inoculating
onto BCYE-s agar was done. Thus, both acid treatment
and using selective agar were found to be more useful for
the isolation of L. pneumophila.

Discussion
In 1976, an outbreak of pneumonia occurred at a
hotel at the site of the American Legion Convention in
Philadelphia. The discovery of L. pneumophila and
Legionnaires’ disease was after this outbreak. L.
pneumophila can survive in a wide range of
environmental conditions. The distribution of L.
pneumophila on man-made aquatic reservoirs, including
water distribution systems and cooling towers, are
related to epidemiology. The incidence of Legionnaires’
disease is dependent on the degree of contamination of
the organism in the aquatic reservoir and the
susceptibility of the persons, availability of specialized
laboratory tests and their application to the infected
patients (1,5-7).
Numerous studies have shown L. pneumophila among
the three most common microbial aetiologies of
community-acquired pneumonia. It is suggested by CDC
investigations that only 3% of sporadic cases of
Legionnaries’ disease are correctly diagnosed. The
incidence of nosocomial pneumonia by Legionella sp. is
dependent on the degree of colonization, the number of
immunosupressed host and the availability of culture
methods. Cigarette smoking, chronic lung disease,
advanced age and immunosupression have been
implicated as risk factors. Excess alcohol intake, renal
failure and surgery are major predisposing factors, with
transplant recipients at highest risk (1,7).
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The aim of this study was to determine the
distribution
of
respiratory
pathogens
in
immunocompromised patients and the role of L.
pneumophila. All of the patients included in this study
were receiving immunosupressive therapy for the
treatment of their primary pathologies.
In granulocytopenia and cellular immune dysfunction,
Gram-negative bacterial infections due to the members of
Enterobacteriaceae and L. pneumophila is common. In
our study, E. coli was isolated from 3, Enterobacter sp.
was isolated from 2 and L. pneumophila was isolated
from 7 sputum samples. Granulocytopenic patients are
also susceptible to infections caused by Gram-positive
bacteria, including S. aureus, S. epidermidis and
streptococci. Also, fungi such as candida sp. and
Aspergillus sp. cause infections. In our study, Aspergillus
sp. was isolated from 3 specimens, yeast from 10
specimens and S. aureus from 1 specimen. M.
tuberculosis and Nocardia sp, which are also common in
cellular immune dysfunction, were also isolated. This
distribution of causative agents is similar to that in the
literature (1-3, 8-10).
Microbiogical diagnosis of nosocomial pneumonia is
particularly difficult, and sputum cultures have very low
sensitivity and specificity. When microorganisms such as
E. coli, S. aureus or Candida sp. are isolated, they may be
aetiologic agents or represent oropharyngeal
colonization. Thus, the approach used in differentiating
them is very important.
The incidence of L. pneumophila varies widely from
study to study, ranging from 1 to 16%. Mortality rates
range from 5% in nonimmunosuppressed patients to 80%
in compromised patients. Pneumonia with L. pneumophila
and other Legionella sp. may occur in patients with a
variety of defects, and its diagnosis is particularly difficult
because of its weak Gram staining and the delay associated
with a serological response of difficult cultures. For
culturing this organism, BCYE agar is one of the media
used. BCYE agar can be used for the isolation of the
organism, but as respiratory specimens, especially sputum
samples, include flora members, their growth does not
allow easy differentiation of L. pneumophila colonies.
Therefore, a more selective medium is recommended.
BCYE-selective agar including antimicrobials for the
inhibition of flora members is more useful (3,4). In our
study, the identification of L. pneumophila was much
easier when BCYE-s agar was used.
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Another approach for the isolation of L. pneumophila
is acid decontamination. If the sputum samples are acid
treated and then cultured, flora members are inhibited,
so isolation may be easier. In our study the results of acid
treatment were similar to those obtained by culturing
onto BCYE-s agar. These two techniques can be
recommended and if both methods are used, accurate
results may be obtained (11-13).

high titre (≥1/128) may indicate acute disease if the
prevalance is low in that population. In our study, by IFA
assay the sera of 3 patients were screened for
L. pneumophila antibodies; 1/256 titre was obtained for
2 patients, indicating acute disease. We can conclude
that IFA is not sufficient for diagnosis; it must be
performed in addition to another technique, especially
culturing.

L. pneumophila is a faintly staining organism, so
microscopic examination of the sputum specimens is
usually insufficient. Microscopic examination is useful anly
when used in combination with another identification
technique.

In conclusion, immunocompromised patients are
susceptible to infections caused by a variety of infectious
agents. L. pneumophila is one of the pathogens that
cannot be isolated by routine diagnostic methods. Our
study showed that it plays an important role in the
pneumonia of immunocompromised patients. For
microbiological diagnosis of pneumonia caused by L.
pneumophila, culturing is the ‘gold standard’ especially
when the specimen is acid decontaminated or inoculated
onto antibiotic-supplemented media. Immunfluorescence
techniques and direct microscopic examination are of
diagnostic value when combined with culturing methods.
Therefore, a combination of techniques must be added to
the routine culturing programmes for the isolation and
identification of L. pneumophila.

There is increasing use of flourescent antibodies for
identification of L. pneumophila in clinical specimens,
suggesting that these methods have good sensitivity. In
our study, the DFA test was applied to the sputum
samples, and in 6 specimens that yielded L. pneumophila,
positive results were obtained (85% sensitivity). Cross
reaction with other organisms was not seen (100%
specificity).
For serological diagnosis of Legionnaires’ disease, a
four-fold increase in antibody titres is required. A single
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